Items where authors include "Qureshi, N."
Article
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736
Salway, S. orcid.org/0000-0002-7688-5496, Yazici, E., Khan, N. et al. (4 more authors) (2019) How should health policy and practice respond to the increased genetic risk associated with close relative marriage? results of a UK Delphi consensus building exercise. BMJ Open, 9 (7). e028928. ISSN 2044-6055
Carroll, C. orcid.org/0000-0002-6361-6182, Tappenden, P. orcid.org/0000-0001-6612-2332, Rafia, R. orcid.org/0000-0002-6914-1990 et al. (6 more authors) (2017) Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35 (5). pp. 537-547. ISSN 1170-7690
Furler, J., Cleland, J., Del Mar, C. et al. (11 more authors) (2008) Leaders, leadership and future primary care clinical research. BMC Family Practice, 9 (1). p. 52. ISSN 1471-2296